Medtech Struggles to Get VC Funds—Report
(Reuters) - Venture capitalists, long the lifeblood of medical technology firms, are growing cautious on the sector after seeing their returns squeezed in a time of growing cost pressures for healthcare, a report by Ernst & Young said.
2 October 2012•3 mins read
